MARI RACHEL ANDERSON

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner PLANTATION, FL NPI 1861925562

General Payments — all program years on this page

$1,038.09

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 48
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $465.81 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $465.8120

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $70.695
2022 $141.217
2023 $360.3816
2024 $465.8120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077975378 Janssen Pharmaceuticals, Inc $17.83 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077975384 Janssen Pharmaceuticals, Inc $19.18 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077975396 Janssen Pharmaceuticals, Inc $17.22 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077975442 Janssen Pharmaceuticals, Inc $18.24 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077975476 Janssen Pharmaceuticals, Inc $16.88 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100489333 Novo Nordisk Inc $23.20 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101589533 E.R. Squibb & Sons, L.L.C. $22.51 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117190309 Amgen Inc. $27.24 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117190311 Amgen Inc. $22.93 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117190313 Amgen Inc. $20.21 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117190315 Amgen Inc. $17.50 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117495068 Amgen Inc. $18.33 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118198749 Boehringer Ingelheim Pharmaceuticals, Inc. $18.34 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118198754 Boehringer Ingelheim Pharmaceuticals, Inc. $24.40 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118198758 Boehringer Ingelheim Pharmaceuticals, Inc. $26.24 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118198762 Boehringer Ingelheim Pharmaceuticals, Inc. $33.29 03/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118198766 Boehringer Ingelheim Pharmaceuticals, Inc. $34.42 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132893193 ATRICURE, INC. $22.07 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154880162 Kiniksa Pharmaceuticals International, plc $39.47 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154880190 Kiniksa Pharmaceuticals International, plc $26.31 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.